v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 200,404 $ 74,317
Short-term investments 300,255 184,792
Restricted cash - short-term 194 194
Accounts receivable 1,250 0
Prepaid expenses and other current assets 21,170 13,689
Total current assets 523,273 272,992
Property and equipment, net 50,517 54,176
Operating lease assets 12,303 14,007
Restricted cash - long-term 1,200 1,200
Other assets 827 567
Total assets 588,120 342,942
Current liabilities:    
Accounts payable 7,118 7,963
Accrued compensation 20,458 14,706
Accrued research and development expenses 15,813 8,341
Deferred revenue 33,455 0
Other current liabilities 6,057 5,733
Total current liabilities 82,901 36,743
Deferred revenue - long-term 27,795 0
Operating lease liabilities - long-term 13,041 14,136
Other long-term liabilities 2,044 1,282
Total liabilities 125,781 52,161
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of December 31, 2020 and 2019, respectively; 83,372 and 56,806 shares issued and outstanding as of December 31, 2020 and 2019, respectively 8 6
Additional paid-in capital 1,586,616 1,108,516
Accumulated other comprehensive income 296 220
Accumulated deficit (1,124,581) (817,961)
Total stockholders’ equity 462,339 290,781
Total liabilities and stockholders’ equity $ 588,120 $ 342,942

Source